{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Genotyping&page=2", "query": { "intervention": "Genotyping", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Genotyping&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-04T19:12:01.412Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03943927", "title": "Preemptive Pharmacogenetic-guided Metoprolol Management for PostoperativeAtrial Fibrillation in Cardiac Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-operative Atrial Fibrillation" ], "interventions": [ { "name": "Guided Metoprolol Management", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 107, "start_date": "2021-03-05", "completion_date": "2022-11-20", "has_results": false, "last_update_posted_date": "2023-03-10", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03943927" }, { "nct_id": "NCT02810327", "title": "Alpha-1 Carrier Genomics Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alpha-1 Antitrypsin Deficiency", "Emphysema", "COPD", "Smoking" ], "interventions": [ { "name": "Genetic Sequencing", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 117, "start_date": "2015-02", "completion_date": "2017-04", "has_results": true, "last_update_posted_date": "2019-07-22", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02810327" }, { "nct_id": "NCT02128542", "title": "Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hepatitis C Virus Infection" ], "interventions": [ { "name": "Sofosbuvir", "type": "DRUG" }, { "name": "RBV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 66, "start_date": "2014-06", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2016-08-03", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 17, "location_summary": "Long Beach, California • Los Angeles, California • Palo Alto, California + 14 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02128542" }, { "nct_id": "NCT03535675", "title": "Muscadine Plus (MPX) In Men With Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Adenocarcinoma of the Prostate" ], "interventions": [ { "name": "Muscadine Plus", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "MALE", "summary": "18 Years to 99 Years · Male only" }, "enrollment_count": 59, "start_date": "2018-10-30", "completion_date": "2022-11-03", "has_results": true, "last_update_posted_date": "2023-05-22", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 13, "location_summary": "Duarte, California • La Jolla, California • Aurora, Colorado + 10 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03535675" }, { "nct_id": "NCT01358864", "title": "Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "BI 201335", "type": "DRUG" }, { "name": "Pegylated Interferon-alpha (IFN)", "type": "DRUG" }, { "name": "Ribavirin (RBV)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 678, "start_date": "2011-06", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2016-08-29", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 18, "location_summary": "North Little Rock, Arkansas • Englewood, Colorado • Palm Harbor, Florida + 14 more", "locations": [ { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Palm Harbor", "state": "Florida" }, { "city": "Columbus", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01358864" }, { "nct_id": "NCT05380531", "title": "Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cesarean Section Complications", "Opioid Use" ], "interventions": [ { "name": "Preoperative Genotyping", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Senthil Sadhasivam", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 700, "start_date": "2022-12-05", "completion_date": "2027-10-30", "has_results": false, "last_update_posted_date": "2026-04-14", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 4, "location_summary": "Indianapolis, Indiana • St Louis, Missouri • Pittsburgh, Pennsylvania", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05380531" }, { "nct_id": "NCT00265590", "title": "Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Aniridia" ], "interventions": [], "intervention_types": [], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 100, "start_date": "2005-12-07", "completion_date": "2008-10-03", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 3, "location_summary": "Chicago, Illinois • Bethesda, Maryland • Cincinnati, Ohio", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00265590" }, { "nct_id": "NCT03428009", "title": "Dystonia Genotype-Phenotype Correlation", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Dystonia", "Dystonia; Idiopathic", "Dystonia, Primary", "Dystonia, Secondary", "Dystonia, Familial", "Dystonia Disorder", "Dystonias, Sporadic", "Dystonia; Orofacial", "Dystonia Lenticularis", "Dystonia, Paroxysmal", "Dystonia 6", "Dystonia 5", "Dystonia 8", "Dystonia 9", "Dystonia 19", "Dystonia 10", "Dystonia 11", "Dystonia 20", "Dystonia 12", "Dystonia, Focal", "Dystonia of Head", "Dystonia, Diurnal" ], "interventions": [ { "name": "Magnetic Resonance Imaging", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": null, "sex": "ALL", "summary": "11 Years and older" }, "enrollment_count": 200, "start_date": "2018-03-01", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2025-06-06", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03428009" }, { "nct_id": "NCT04857528", "title": "Detecting HPV DNA in Anal and Cervical Cancers", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cervical Cancer", "Anal Cancer", "HPV-Related Anal Squamous Cell Carcinoma", "HPV-Related Cervical Carcinoma", "HPV-Related Carcinoma", "Uterine Cervical Cancer" ], "interventions": [ { "name": "Radiation Treatment With or Without Chemotherapy", "type": "RADIATION" }, { "name": "Blood Sample Collection", "type": "OTHER" }, { "name": "HPV Genotyping (HPV DNA Test)", "type": "DIAGNOSTIC_TEST" }, { "name": "Testing Archival Tumor Tissue", "type": "DIAGNOSTIC_TEST" }, { "name": "Physical Exam", "type": "OTHER" }, { "name": "Positron Emission Tomography Scan (PET Scan)/ Computed Tomography Scan (CT Scan)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "RADIATION", "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2020-10-06", "completion_date": "2027-11-15", "has_results": false, "last_update_posted_date": "2026-03-04", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 2, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04857528" }, { "nct_id": "NCT03038763", "title": "Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatitis C", "Hepatitis C, Chronic" ], "interventions": [ { "name": "Eligibility Screening", "type": "OTHER" }, { "name": "HCV test", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "72 Years", "sex": "ALL", "summary": "18 Years to 72 Years" }, "enrollment_count": 100, "start_date": "2017-05-11", "completion_date": "2019-06-30", "has_results": false, "last_update_posted_date": "2019-07-17", "last_synced_at": "2026-09-04T19:12:01.412Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03038763" } ] }